SciELO - Scientific Electronic Library Online

 
vol.45 issue2Therapy with infliximab in active Behçet's diseaseHyperbaric oxygen therapy in patients of a pediatric rheumatology service author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Reumatologia

Print version ISSN 0482-5004

Abstract

FREITAS, Sinara da Silva et al. Infliximab treatment for refractory posterior uveitis in Behçet's disease. Rev. Bras. Reumatol. [online]. 2005, vol.45, n.2, pp. 94-97. ISSN 0482-5004.  http://dx.doi.org/10.1590/S0482-50042005000200010.

Permanent vision loss resulting from relapsing ocular inflammation occurs frequently in patients with Behçet's disease, despite intensive and chronic immunosuppressive therapy. The authors report the case of a 35-year-old man with chronic bilateral posterior uveitis refractory to corticosteroids and immunosuppressive agents (methotrexate and cyclosporine) with a beneficial effect from treatment with infliximab.

Keywords : tumor necrosis factor; Behçet syndrome; posterior uveitis.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese